COVID-19 Comorbidities: How Do Underlying Hypertensive and Cardiovascular Conditions Affect the Prognosis and Therapies of COVID-19?

Huiyi Xiong

2022

Abstract

The coronavirus disease 2019 (COVID-19), a contagious disease caused by the SARS-CoV-2 virus, spread worldwide in a short period and affected the lives of billions of people. Recent studies have found that many COVID-19 patients have underlying comorbidities that lead to acute disease prognosis and more severe complications of COVID-19 symptoms. Among all common comorbidities, hypertension and cardiovascular-related diseases appear more frequently in patients. In this review, we investigate the bidirectional interaction between COVID-19 and the cardiovascular system by clarifying the effects of SARS-CoV-2 infection on underlying hypertension conditions and cardiovascular disorders and how hypertension and cardiovascular diseases affect the mortality and prognosis COVID-19. Combined with analysis of promising but currently controversial remedies for COVID-19, such as anti-hypertensive therapies that use ARBs and ACE inhibitors and other treatments of acute COVID-19 cardiovascular syndrome, we could better understand the interactions between SARS-CoV-2 virus and hypertensive-cardiovascular related comorbidities to develop safer and more effective treatments for COVID-19.

Paper Citation

in Harvard Style

Xiong H. (2022). COVID-19 Comorbidities: How Do Underlying Hypertensive and Cardiovascular Conditions Affect the Prognosis and Therapies of COVID-19?. In Proceedings of the 1st International Conference on Health Big Data and Intelligent Healthcare - Volume 1: ICHIH, ISBN 978-989-758-596-8, pages 584-590. DOI: 10.5220/0011515700003438

in Bibtex Style

@conference{ichih22,
author={Huiyi Xiong},
title={COVID-19 Comorbidities: How Do Underlying Hypertensive and Cardiovascular Conditions Affect the Prognosis and Therapies of COVID-19?},
booktitle={Proceedings of the 1st International Conference on Health Big Data and Intelligent Healthcare - Volume 1: ICHIH,},
year={2022},
pages={584-590},
publisher={SciTePress},
organization={INSTICC},
doi={10.5220/0011515700003438},
isbn={978-989-758-596-8},
}

in EndNote Style

TY - CONF

JO - Proceedings of the 1st International Conference on Health Big Data and Intelligent Healthcare - Volume 1: ICHIH,
TI - COVID-19 Comorbidities: How Do Underlying Hypertensive and Cardiovascular Conditions Affect the Prognosis and Therapies of COVID-19?
SN - 978-989-758-596-8
AU - Xiong H.
PY - 2022
SP - 584
EP - 590
DO - 10.5220/0011515700003438